Creatine and Creatinine Metabolism - Physiological Reviews
Creatine and Creatinine Metabolism - Physiological Reviews
Creatine and Creatinine Metabolism - Physiological Reviews
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
1196 MARKUS WYSS AND RIMA KADDURAH-DAOUK Volume 80<br />
the lipid peroxidation product 4-hydroxynonenal. J Neurochem<br />
69: 273–284, 1997.<br />
472. KEMP GJ, TAYLOR DJ, DUNN JF, FROSTICK SP, AND RADDA GK.<br />
Cellular energetics of dystrophic muscle. J Neurol Sci 116: 201–<br />
206, 1993.<br />
473. KENT-BRAUN JA, SHARMA KR, MILLER RG, AND WEINER MW.<br />
Postexercise phosphocreatine resynthesis is slowed in multiple<br />
sclerosis. Muscle Nerve 17: 835–841, 1994.<br />
474. KENYON GL AND REED GH. <strong>Creatine</strong> kinase: structure-activity<br />
relationships. Adv Enzymol 54: 367–426, 1983.<br />
475. KHANNA NK AND MADAN BR. Studies on the anti-inflammatory<br />
activity of creatine. Arch Int Pharmacodyn 231: 340–350, 1978.<br />
476. KHUCHUA ZA, VASILJEVA EV, CLARK JF, KORCHAZHKINA OV,<br />
BRANISHTE T, KAPELKO VI, KUZNETSOV AV, VENTURA-<br />
CLAPIER R, STEINSCHNEIDER AY, LAKOMKIN VL, RUUGE EK,<br />
AND SAKS VA. The creatine kinase system <strong>and</strong> cardiomyopathy.<br />
Am J Cardiovasc Pathol 4: 223–234, 1992.<br />
477. KIDA M, FUJIWARA H, ISHIDA M, KAWAI C, OHURA M, MIURA<br />
I, AND YABUUCHI Y. Ischemic preconditioning preserves creatine<br />
phosphate <strong>and</strong> intracellular pH. Circulation 84: 2495–2503, 1991.<br />
478. KIDA M, FUJIWARA H, UEGAITO T, MIYAMAE M, OHURA M,<br />
MIURA I, AND YABUUCHI Y. Dobutamine prevents both myocardial<br />
stunning <strong>and</strong> phosphocreatine overshoot without affecting<br />
ATP level. J Mol Cell Cardiol 25: 875–885, 1993.<br />
479. KIKUCHI T, ORITA Y, ANDO A, MIKAMI H, FUJII M, OKADA A,<br />
AND ABE H. Liquid-chromatographic determination of guanidino<br />
compounds in plasma <strong>and</strong> erythrocytes of normal persons <strong>and</strong><br />
uremic patients. Clin Chem 27: 1899–1902, 1981.<br />
480. KIM GS, CHEVLI KD, AND FITCH CD. Fasting modulates creatine<br />
entry into skeletal muscle in the mouse. Experientia 39: 1360–<br />
1362, 1983.<br />
481. KIM I-S, WAKABAYASHI K, KUROSAKA R, YAMAIZUMI Z, JINNO<br />
F, KOYOTA S, TADA A, NUKAYA H, TAKAHASHI M, SUGIMURA<br />
T, AND NAGAO M. Isolation <strong>and</strong> identification of a new mutagen,<br />
2-amino-4-hydroxymethyl-3,8-dimethylimidazo[4,5-f]quinoxaline<br />
(4-CH 2OH-8-MeIQx), from beef extract. Carcinogenesis 15: 21–26,<br />
1994.<br />
482. KIM JM, SHIMIZU S, AND YAMADA H. Amidohydrolysis of Nmethylhydantoin<br />
coupled with ATP hydrolysis. Biochem Biophys<br />
Res Commun 142: 1006–1012, 1987.<br />
483. KIM JM, SHIMIZU S, AND YAMADA H. Crystallization <strong>and</strong> characterization<br />
of sarcosine oxidase from Alcaligenes denitrificans<br />
subsp. denitrificans. Agric Biol Chem 51: 1167–1168, 1987.<br />
484. KIM JM, SHIMIZU S, AND YAMADA H. Cytosine deaminase that<br />
hydrolyzes creatinine to N-methylhydantoin in various cytosine<br />
deaminase-forming microorganisms. Arch Microbiol 147: 58–63,<br />
1987.<br />
485. KIM JM, SHIMIZU S, AND YAMADA H. Evidence for the presence<br />
of a cytosine deaminase that does not catalyze the deimination of<br />
creatine. FEBS Lett 210: 77–80, 1987.<br />
486. KIM JM, SHIMIZU S, AND YAMADA H. Purification <strong>and</strong> characterization<br />
of a novel enzyme, N-carbamoylsarcosine amidohydrolase,<br />
from Pseudomonas putida 77. J Biol Chem 261: 11832–11839,<br />
1986.<br />
487. KIM JM, SHIMIZU S, AND YAMADA H. Sarcosine oxidase involved<br />
in creatinine degradation in Alcaligenes denitrificans subsp.<br />
denitrificans J9 <strong>and</strong> Arthrobacter spp J5 <strong>and</strong> J11. Agric Biol<br />
Chem 50: 2811–2816, 1986.<br />
488. KINOSHITA Y AND YOKOTA A. Absolute concentrations of metabolites<br />
in human brain tumors using in vitro proton magnetic<br />
resonance spectroscopy. NMR Biomed 10: 2–12, 1997.<br />
489. KLIVENYI P, FERRANTE RJ, MATTHEWS RT, BOGDANOV MB,<br />
KLEIN AM, ANDREASSEN OA, MUELLER G, WERMER M, KAD-<br />
DURAH-DAOUK R, AND BEAL MF. Neuroprotective effects of<br />
creatine in a transgenic animal model of amyotrophic lateral<br />
sclerosis. Nature Med 5: 347–350, 1999.<br />
490. KLUSHNIK TP, SPUNDE AY, YAKOVLEV AG, KHUCHUA ZA,<br />
SAKS VA, AND VARTANYAN ME. Intracellular alterations of the<br />
creatine kinase isoforms in brains of schizophrenic patients. Mol<br />
Chem Neuropathol 15: 271–280, 1991.<br />
491. KNIZE MG, CUNNINGHAM PL, AVILA JR, JONES AL, GRIFFIN<br />
EA, AND FELTON JS. Formation of mutagenic activity from amino<br />
acids heated at cooking temperatures. Food Chem Toxicol 32:<br />
55–60, 1994.<br />
492. KNIZE MG, DOLBEARE FA, CARROLL KL, MOORE DH, AND<br />
FELTON JS. Effect of cooking time <strong>and</strong> temperature on the heterocyclic<br />
amine content of fried beef patties. Food Chem Toxicol<br />
32: 595–603, 1994.<br />
493. KNIZE MG, HOPMANS E, AND HAPPE JA. The identification of a<br />
new heterocyclic amine mutagen from a heated mixture of creatine,<br />
glutamic acid <strong>and</strong> glucose. Mutat Res 260: 313–319, 1991.<br />
494. KNIZE MG, ROPER M, SHEN NH, AND FELTON JS. Proposed<br />
structures for an amino-dimethylimidazofuropyridine mutagen in<br />
cooked meats. Carcinogenesis 11: 2259–2262, 1990.<br />
495. KNIZE MG, SALMON CP, HOPMANS EC, AND FELTON JS. Analysis<br />
of foods for heterocyclic aromatic amine carcinogens by<br />
solid-phase extraction <strong>and</strong> high-performance liquid chromatography.<br />
J Chromatogr A 763: 179–185, 1997.<br />
496. KONISHI K AND FUJIOKA M. Reversible inactivation of recombinant<br />
rat liver guanidinoacetate methyltransferase by glutathione<br />
disulfide. Arch Biochem Biophys 289: 90–96, 1991.<br />
497. KONOREV EA, HOGG N, AND KALYANARAMAN B. Rapid <strong>and</strong><br />
irreversible inhibition of creatine kinase by peroxynitrite. FEBS<br />
Lett 427: 171–174, 1998.<br />
498. KOPETZKI E, LEHNERT K, AND BUCKEL P. Enzymes in diagnostics:<br />
achievements <strong>and</strong> possibilities of recombinant DNA technology.<br />
Clin Chem 40: 688–704, 1994.<br />
499. KOPPER PH AND BEARD HH. Creatinase activity of a strain of<br />
Pseudomonas. Arch Biochem 15: 195–199, 1947.<br />
500. KOPPER PH AND ROBIN L. The metabolic breakdown of sarcosine<br />
by a strain of Pseudomonas aeruginosa. Arch Biochem 26: 458–<br />
460, 1950.<br />
501. KORECKY B AND BRANDEJS-BARRY Y. Effect of creatine depletion<br />
on myocardial mechanics. Basic Res Cardiol 82 Suppl 2:<br />
103–110, 1987.<br />
502. KORETSKY AP. Insights into cellular energy metabolism from<br />
transgenic mice. Physiol Rev 75: 667–688, 1995.<br />
503. KORGE P AND CAMPBELL KB. The effect of changes in iron redox<br />
state on the activity of enzymes sensitive to modification of SH<br />
groups. Arch Biochem Biophys 304: 420–428, 1993.<br />
504. KÔRGE P AND CAMPBELL KB. Iron effects on myocardial enzymes<br />
depend on redox state. J Mol Cell Cardiol 26: 151–162,<br />
1994.<br />
505. KÔRGE P, SILBER ML, AND GOLLNICK PD. Effect of creatine<br />
phosphate on the contractile activity in acutely failing rat heart.<br />
Cardiologia 43: 1345–1354, 1998.<br />
506. KORNELUK RG, MACKENZIE AE, NAKAMURA Y, DUBÉ I, JA-<br />
COB P, AND HUNTER AGW. A reordering of human chromosome<br />
19 long-arm DNA markers <strong>and</strong> identification of markers flanking<br />
the myotonic dystrophy locus. Genomics 5: 596–604, 1989.<br />
507. KOSHY KM, GRISWOLD E, AND SCHNEEBERGER EE. Interstitial<br />
nephritis in a patient taking creatine. N Engl J Med 340: 814–815,<br />
1999.<br />
508. KOST GJ, KIRK D, AND OMAND K. A strategy for the use of cardiac<br />
injury markers (troponin I <strong>and</strong> T, creatine kinase-MB mass <strong>and</strong><br />
isoforms, <strong>and</strong> myoglobin) in the diagnosis of acute myocardial<br />
infarction. Arch Pathol Lab Med 122: 245–251, 1998.<br />
509. KRAUSE SM. Effect of global myocardial stunning on Ca 2� -sensitive<br />
myofibrillar ATPase activity <strong>and</strong> creatine kinase kinetics.<br />
Am J Physiol Heart Circ Physiol 259: H813–H819, 1990.<br />
510. KREIDER RB, FERREIRA M, WILSON M, GRINDSTAFF P, PLISK<br />
S, REINARDY J, CANTLER E, AND ALMADA AL. Effects of creatine<br />
supplementation on body composition, strength, <strong>and</strong> sprint<br />
performance. Med Sci Sports Exercise 30: 73–82, 1998.<br />
511. KREIDER RB, KLESGES R, HARMON K, GRINDSTAFF P, RAM-<br />
SEY L, BULLEN D, WOOD L, LI Y, AND ALMADA A. Effects of<br />
ingesting supplements designed to promote lean tissue accretion<br />
on body composition during resistance training. Int J Sports Nutr<br />
6: 234–246, 1996.<br />
512. KRISTENSEN CA, ASKENASY N, JAIN RK, AND KORETSKY AP.<br />
<strong>Creatine</strong> <strong>and</strong> cyclocreatine treatment of human colon adenocarcinoma<br />
xenografts: 31 P <strong>and</strong> 1 H magnetic resonance spectroscopic<br />
studies. Br J Cancer 79: 278–285, 1999.<br />
513. KRISTENSEN CA, KRISTJANSEN PEG, BRÜNNER N, QUIS-<br />
TORFF B, AND SPANG-THOMSEN M. Growth inhibition in re-